Anti-Nuclear Antibodies in Daily Clinical Practice: Prevalence in Primary, Secondary, and Tertiary Care

For the diagnosis of systemic autoimmune rheumatic diseases (SARD), patients are screened for anti-nuclear antibodies (ANA). ANA, as assessed by indirect immunofluorescence (IIF), have a poor specificity. This hampers interpretation of positive results in clinical settings with low pretest probabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Avery, Thomas Y., van de Cruys, Mart, Austen, Jos, Stals, Frans, Damoiseaux, Jan G. M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987797/
https://www.ncbi.nlm.nih.gov/pubmed/24741596
http://dx.doi.org/10.1155/2014/401739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987797/
https://www.ncbi.nlm.nih.gov/pubmed/24741596
http://dx.doi.org/10.1155/2014/401739

Ejemplares similares